Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares
18. Dezember 2024 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug...
Inotiv, Inc. Launches Proposed Public Offering of Common Shares
17. Dezember 2024 16:03 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug...
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
03. Dezember 2024 16:05 ET
|
Inotiv, Inc.
— Enhanced liquidity through issuance of Second Lien Notes — Obtained amendment to credit agreement and extended note payable — Fourth quarter fiscal 2024 revenue down 7.3% to $130.4 million — ...
Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
21. November 2024 08:30 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 138 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media,...
Inotiv, Inc. to Report Fiscal 2024 Fourth Quarter and Full Year Results and Host Conference Call on Tuesday, December 3, 2024
20. November 2024 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv, Inc. to Participate in Upcoming Jefferies and Craig-Hallum Investor Conferences
07. November 2024 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv, Inc. Amends Its Credit Agreement and Secures Additional Liquidity
16. September 2024 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
28. August 2024 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and...
Inotiv Reports Third Quarter Financial Results for Fiscal 2024 and Provides Business Update
08. August 2024 16:05 ET
|
Inotiv, Inc.
— Third quarter fiscal 2024 revenue down 32.8% to $105.8 million — Year-to-date fiscal 2024 revenue down 16.5% to $360.3 million — Conclusion of certain government investigations — Site optimization...
Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024
25. Juli 2024 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 25, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...